Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Soft Tissue Sarcoma
Interventions: DRUG: Temozolomide
Sponsor: University of Washington
Collaborators: Schering-Plough